INTRODUCTION
There is now a convincing body of evidence that the toxic effects of arsenicals are referable primarily to the fact that they combine with -SH groups in the tissues, and thus block one or more physiologic sytems vital to the cellular economy. The toxic action of 3-amino-4-hydroxyphenyl arsenoxide against both trypanosomes and rats has been shown to be diminished or abolished by cyseine or glutathione ( 1 to 3) Cysteine also delayed the toxic action of sodium arsenite in mice (4) ; and a similar inhibition of the neurotoxic action of sodium arsenite was observed in vitro (5) . It was further shown (6, 7, 7a) that the toxic effects of arsenicals were not only prevented, but could actually be reversed by -SH compounds. Protozoa (Colpidium) already immobilized by diphenyldichloroarsine, and spirochetes (S. pallida) immobilized by phenyl arsenoxides, were resuscitated on the addition of monothioethyleneglycol and cysteine respectively.
The foregoing observations were indicative of the strong affinity of arsenicals for -SH groups, as already noted by Ehrlich (8) , but did not necessarily prove that arsenicals owed their toxic effects to the fact that they combined with -SH groups in tissue. The missing link in this chain of evidence was provided by the observation that when arsenicals combined with tissue proteins, the reactive -SH groups of the latter simultaneously disappeared (9 to 11). The widely varying systemic toxicity of a series of phenyl arsenoxides was shown to be correlated with, and probably determined by, the varying degree to which they were bound by the host tissues (12); and a high degree of correlation was noted (13) between the trypanocidal action of phenyl arsenoxides and the extent to which they were bound by the trypanosomes. Finally, a series of enzyme proteins containing free -SH groups were shown to be reversibly inactivated by arsenicals in vitro, with the disappearance of the titratable -SH groups (14, 15) . The implication that the toxic action of arsenicals is referable to the inactivation of similar -SH-containing enzyme proteins in living cells is clear.
Although monothiol compounds had been found to protect against the toxic action of some arsenicals, and in isolated cases actually to reverse that toxic effect, the antidotal action was not regular. Cysteine and glutathione delayed, but did not-prevent, the toxic action of sodium arsenite on the medullated nerves of frogs, measured either by their respiration or by their action potential (5) . Moreover, once the action current had been abolished, even a large excess of sulfhydryl compound failed to induce recovery. Similarly, monothiols in general failed to prevent the inhibition by sodium arsenite or Lewisite of the pyruvate oxidase system' in a pigeon brain "brei" (15, 16), or the respiration of rat skin slices (16), and failed also to protect human or rat skin from the vesicant action of Lewisite (17, 18) . Even with the trivalent aromatic arsenicals studied by Voegtlin and his co-workers and by Eagle, a 10-to 40-fold excess of cysteine or glutathione was required to prevent toxic effects in vitro; the latter compound was most effective in vivo if administered immediately before the arsenical (2.); and if even a few minutes were allowed to elapse between the injection into rabbits of a lethal dose of the 3-NH24-OH-phenyl arsenoxide and a following injection of cysteine or glutathione, the lattr->ad no protective action (Table I) . The early use of BAL was limited to its local application in the treatment of experimental Lewisite bums, or of the arsenical dermatitis resulting from antisyphilitic treatment. It seemed clear, however, that the drug so applied had a systemic as well as local action. Thus the application of BAL to a skin area of rats 15 minutes after its contamination with Lewisite resulted in a 4-fold increase in the urinary excretion of arsenic (22). Similarly, the urinary excretion of arsenic increased in human cases of exfoliative dermatitis caused by mapharsen, and treated by the local application of BAL ointment (23). Moreover, BAL ointment was therapeutically effective in such cases when applied to normal skin distant. from the lesion. These results clearly indicated that BAL was absorbed through the skin in sufficient quantity to have a systemic effect; and it seemed likely that BAL given by injection might have a therapeutic effect in the treatment of arsenic poisoning.
This was borne out by the finding (19) that aqueous solutions of BAL (50 to 60 mngm. per 'kgm.>' injected intraperitoneally into rats 1 to 2 hours after the skin application of a lethal dose of Lewisite saved 67 to 83 per cent of the animals, and that all were saved by an initial dose of 60 to 70 mgm. per kgm., followed by a second smaller dose 3% hours later.
Our initial expernments on this point (24) dealt with animals poisoned by the systemic administration of mapharsen. As shown in Table I Table. There was no significant difference between rabbits injected intravenously, intramuscularly or subcutaneously, and they are not distinguished in the Table. with skin applications of Lewisite (26) HCI (or NH3) gas passed through a peanut oil solution containing 10 grams BAL and 20 grams benzyl benzoate per 100 ml. These solutions were then mixed with the stock untreated solution in varying proportions, and each dilution was further mixed with an equal volume of peanut oil to give solutions containing 5 per cent BAL and 10 per cent benzyl benzoate. The pH of aqueous extracts of each preparation was determined (29) before and after sterilization of the oil in glass-sealed tubes under air at 1700 C. (1 hour). Two ml. of each mixture were shaken vigorously with 2 ml. H20 for 2 minutes. The H20 layer was removed after centrifugation, and its pH determined with a glass electrode (Beckman pH meter). The degree to which the BAL had deteriorated on sterilization was determined by direct iodometric titration of a suspension of the oil in a large excess of water. * Stock solution, not treated with HCI or NH3. due in part to oxidizing substances in the peanut oil, in part to the presence of traces of water, and to a lesser extent, to the small amount of oxygen in the free air space of the tube in which the solution was sterilized. Once these substances had been consumed, there was no further loss on additional heating or aging. While this degree of loss is slight, it should nevertheless be measured in the preparation and processing of every lot of BAL solution.
2. Toxicity of peanut oil-benzyl benzoate solution of BAL in rabbits. The toxicity of the BALbenzylbenzoate-peanut oil mixture in rabbits is summarized in Tables IV and V. The toxicity was a function of the total amount of BAL administered, and was independent of its concentration. In studying the tissue damage produced by such solutions at the site of injection, 5 and 10 per cent solutions in peanut oil, containing 10 and 20 per cent respectively of benzyl benzoate, did not cause undue local damage when injected intra- In the systemic use of BAL for the treatment of arsenic poisoning, the latter is perhaps the more important reaction. Highly toxic arsenicals combine with the tissues rapidly (12); and in the case of arsenic compounds used therapeutically, a toxic complication which indicates the use of BAL is presumably the result of a similar combination of arsenic with cellular thiol groups.
That sulfhydryl compounds in general can dissociate arsenic from its combination with cells was indicated by the observation (6) that protozoa (Colpidium) immobilized by dichloroarsine could be resuscitated by the addition of monothioethylene glycol, and the similar observation (7, 7a) that S. pallida immobilized by a series of phenyl arsenoxides could be resuscitated by cysteine. The even more striking effect of BAL in reviving trypanosomes immobilized by aromatic arsenicals (24) is illustrated in Table IX . Suspensions of trypanosomes (T. equiperdum) were exposed to a final concentration of phenyl arsenoxide (1.3 x 10-5 molar = 1: 460,000) which caused their complete immobilization within less than 1 minute. Within 5 minutes obvious degenerative changes had become evident in most of the organisms, which tended to increase in size, to assume a globular shape, and to become vacuolated; and in the following 30 minutes a significant proportion had completely lysed. At varying intervals after the admixture of arsenical and organisins, aliquot portions were withdrawn and added to varying concentrations of BAL and cysteine. As little as 3 molar equivalents of BAL added to the poisoned -The effect of BAL in resuscitating organisms immobilized and poisoned by arsenicals is related to the fact that it abstracts the arsenic from the cells. As is indicated in Table X , actively trypanocidal compounds may be concentrated by the organisms more than 200-fold. On the addition of BAL, the arsenical is rapidly removed, and the concentration in the cells is reduced to a nonlethal level. Since the widely varying trypanocidal activity of a series of trivalent arsenicals is determined by the degree to which these compounds are bound by the organisms (13), one may conclude that the demonstrated ability of BAL to remove arsenic from its combination with cell components is the basis of its efficacy in reversing the toxic action of arsenicals.
In the animal body also, the protective action of BAL is associated with an increased excretion of arsenic. Stocken and Thompson (22) demonstrated a 4-fold increase in rate after the local application of BAL to a skin area burned with Lewisite. In rabbits poisoned with phenyl arsenoxide or Lewisite, and to a lesser extent, with mapharsen, we have found a striking increase in the rate of urinary arsenic excretion on systemic treatment with BAL. It had been previously shown in this laboratory (12) that the rate of excretion of arsenicals was related to their toxicity: the more toxic the compound, the slower it was excreted, presumably because of its firmer and more extensive combination with the host tissues. Thus, in the first 24 to 72 hours after the injection of phenyl arsenoxide (0.56 mgm. per kgm. = 0.0033 millimols per kgm.) into rabbits, the hourly urinary excretion was only 0.12 to 0.35 per cent of 460) the amount injected (Table XI) . The administration of BAL to such rabbits, whether intravenously in aqueous solution (Figure 1 ) or subcutaneously in peanut oil (Figure 2) , caused a striking increase in the rate of urinary excretion. The greatest effect was observed when BAL was given immediately after the arsenical, in which case the hourly excretion reached as high as 21.9 per cent, or approximately a hundredfold increase over control rabbits.
It is to be noted that the effect of the BAL was temporary. After both intravenous and intramuscular injection, with both aqueous and oil solutions respectively, its action was largely completed within 2 to 4 hours. By that time all the BAL had presumably been either excreted, or metabolized to an inactive form. Further, with multiple injections of BAL, each injection was followed by a definite spurt in urinary excretion. These observations suggested the advisability of administering BAL in repeated small doses, rather than a single massive dose, a procedure already indicated on the basis of minimum toxicity and maximum efficacy (Tables IV to VII). A single experiment with Lewisite is summarized in Figure 3 . BAL in peanut oil (10 mgm. per kgm.) administered intramuscularly 24 hours after the intravenous injection of 0.0033 moles per kgm. Lewisite caused a definite increase in the rate of urinary arsenic excretion, sustained for a period of 2 to 4 hours.
One of many similar experiments with mapharsen is summarized in Figure 4 . As is there illustrated, with this compound the effect of BAL on urinary excretion, although definite, was less pronounced than in the case of either phenyl arsenoxide or Lewisite. This probably reflects the several facts (a) that much larger doses of ** 3 X 109 trypanosomes = 0.12 ml. Thus, in the experiment with 4-CONH2 phenyl arsenoxide, 1.9 X 10' trypanosomes, measuring 0.076 ml., contained 12.7 'y As, or 167 -y per ml. The supernatant fluid contained 0.65 -y per ml., giving a concentration ratio of 257. t 9.8 ml. of supernatant contained 5.3 micrograms arsenic. $ 9.6 ml. of supernatant contained 10.5 micrograms arsenic. (34) . ** Average hourly excretion in absence of BAL taken as 0.18 per cent of amount injected (cf. column 5).
mapharsen were used than in the case of the other more toxic arsenoxides, and (b) that mapharsen is normally excreted at a faster rate than is either Lewisite or phenyl arsenoxide (12). In consequence, the increased excretion resulting from the administration of BAL was partially obscured by the significant amounts excreted without reference to BAL.
As in the case of microorganisms, the increased rate of excretion of arsenic caused by BAL, and its therapeutic efficacy, are presumably due to the fact that it abstracts the arsenical from an otherwise firm combination with the tissue cells, with the release of vital tissue thiol groups and the excretion of the BAL-thioarsenite. The nature of the chemical grouping in the cells with which the arsenic combines to exert its toxic action has been discussed in a preceding section.
It should be emphasized thiat thiol compounds, including BAL, successfully reversed the toxic action of arsenicals on spirochetes or trypanosomes only if applied soon after the organisms are immobilized. Beyond that period secondary reactions apparently occur, so that the mere removal of the arsenical does not then suffice to restore cell function (6, 7a figure. treatment with BAL, at doses approaching the toxic range of the BAL itself, was ineffective (24) .
The implication is clear that for optimum results, BAL should be administered as soon as possible after exposure to toxic arsenicals, or after the development of toxic manifestations as a complication of arsenical chemotherapy. In patients heavily exposed to arsenical blister gases, local decontamination with BAL to remove the surface material should be supplemented by its prompt systemic administration to counteract the effects of the material already absorbed.
The effect of BAL on the urinary excretion of arsenic in normal human volunteers, in subjects exposed to an arsenical smoke, and in human cases of arsenic poisoning are discussed in following papers of this series (35, 23) . The results obtained with BAL in the treatment of 227 cases of arsenic poisoning (encephalitis, dermatitis, blood dyscrasias, jaundice, fever) will be described elsewhere (32, 35 formed. Trypanosomes rapidly immobilized and apparently killed by arsenicals were resuscitated on the addition of BAL, due to the removal of the bound arsenic from the cell. Similarly, in rabbits injected with mapharsen, Lewisite or phenyl arsenoxide, the administration of BAL caused a striking increase in the rate of urinary arsenic excretion, in some cases exceeding a hundred-fold.
3. Although BAL was unstable in aqueous or propylene glycol solution, solutions in peanut oil could be sterilized by heat with only slight loss in activity. With the addition of 2 grams of benzyl benzoate for each gram of BAL, the latter was miscible with peanut oil in all proportions. The toxicity of such solutions in peanut oil and benzyl benzoate was determined in relation to the frequency and number of injections, the route of administration, and the concentration of the solution.
5. BAL dissolved in peanut oil and benzyl benzoate injected intramuscularly proved effective in the treatment of mapharsen, Lewisite and phenyl arsenoxide poisoning in rabbits.
6. The widest margin of safety between the effective and toxic levels of BAL so administered was provided by a schedule involving 4 injections at 2-to 4-hour intervals, followed in some cases by daily injeclions for 6 (20, 21) .
